Physician profile

Ted Gutowski

Cardiovascular Disease · Freehold, NJ

NPI 1669476073

$3,800.78

in general payments reported to CMS, 2019-2025

22 companies · $256 in 2025

The $256 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$691.87

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $1,507.34 2019
Novartis Pharmaceuticals Corporation $876.87 2019-2022
Irhythm Technologies, INC. $270.90 2023-2024 Zio Xt Patch, Zio Monitor
Pfizer INC. $198.44 2019-2023
Janssen Pharmaceuticals, INC $156.58 2019-2022
Abiomed $142.68 2025
Novo Nordisk INC $115.64 2024-2025 Wegovy, Rybelsus, Ozempic
Amgen INC. $74.83 2019
Sanofi-Aventis U.S. LLC $68.38 2019
Scpharmaceuticals INC. $55.47 2023-2024
Boehringer Ingelheim Pharmaceuticals, INC. $53.57 2019
Abbott Laboratories $51.24 2019
Amarin Pharma, INC. $43.27 2019-2020
Boston Scientific Corporation $29.29 2019
Akcea Therapeutics, INC. $29.13 2019-2020
Show all 22 companies
CompanyGeneral paymentsYearsTop products
Gilead Sciences, INC. $25.38 2019
E.R. Squibb & Sons, L.L.C. $23.00 2019-2020
Philips North America LLC $21.34 2019
Impulse Dynamics (USA) INC. $17.35 2024 Optimizer
Kestra Medical Technology Services, INC. $15.78 2025 Assure Wcd
Bayer Healthcare Pharmaceuticals INC. $13.50 2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $10.80 2023 Lifevest

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ted Gutowski

$3,800.78

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic Vascular, INC.
Context
The $256 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/120490/ted-gutowski

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.